Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Scheen

Showing results (161-170 of 787) with videos related to

Pageof 79
Sort By:
Revue Medicale De Liege|May 24, 2000
[Pharma-clinics. Medication of the month. Glimepiride (Amarylle)]A J Scheen
Revue Medicale De Liege|May 24, 2000
[Clinical study of the month. After DCCT, the EDIC study]A J Scheen
Annales D'Endocrinologie|October 16, 1999
[How to assess insulin action in man in research and clinical practice]A J Scheen
Revue Medicale De Liege|December 10, 1999
[Clinical study of the month. Usefulness of increasing HDL cholesterol in secondary prevention of coronary heart disease: results of the VA-HIT study]A J Scheen
Revue Medicale De Liege|August 14, 1999
[Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation]A J Scheen
Revue Medicale De Liege|April 19, 2000
[Antioxidant vitamins in the prevention of cardiovascular diseases. 2nd part: results of clinical trials]A J Scheen
Revue Medicale De Liege|May 10, 2000
[Pharma-clinics. Medication of the month. Moxonidine (Moxon)]A J Scheen
Revue Medicale De Liege|February 25, 2000
[Therapeutic non-compliance: a major problem in the prevention of cardiovascular diseases]A J Scheen
Diabetes & Metabolism|November 28, 2018
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetesA J Scheen
Revue Medicale De Liege|January 5, 2002
[Info-Meeting. Pharmacologic prevention of the progression from impaired glucose tolerance to type 2 diabetes: favorable effects of metformin and acarbose]A J Scheen
Pageof 79

Showing results (161-170 of 787) with videos related to

Sort By:
Pageof 79
Revue Medicale De Liege|May 24, 2000
[Pharma-clinics. Medication of the month. Glimepiride (Amarylle)]A J Scheen
Revue Medicale De Liege|May 24, 2000
[Clinical study of the month. After DCCT, the EDIC study]A J Scheen
Annales D'Endocrinologie|October 16, 1999
[How to assess insulin action in man in research and clinical practice]A J Scheen
Revue Medicale De Liege|December 10, 1999
[Clinical study of the month. Usefulness of increasing HDL cholesterol in secondary prevention of coronary heart disease: results of the VA-HIT study]A J Scheen
Revue Medicale De Liege|August 14, 1999
[Clinical study of the month. Prevention of cerebral vascular accidents in patients with atrial fibrillation]A J Scheen
Revue Medicale De Liege|April 19, 2000
[Antioxidant vitamins in the prevention of cardiovascular diseases. 2nd part: results of clinical trials]A J Scheen
Revue Medicale De Liege|May 10, 2000
[Pharma-clinics. Medication of the month. Moxonidine (Moxon)]A J Scheen
Revue Medicale De Liege|February 25, 2000
[Therapeutic non-compliance: a major problem in the prevention of cardiovascular diseases]A J Scheen
Diabetes & Metabolism|November 28, 2018
Effects of glucose-lowering agents on surrogate endpoints and hard clinical renal outcomes in patients with type 2 diabetesA J Scheen
Revue Medicale De Liege|January 5, 2002
[Info-Meeting. Pharmacologic prevention of the progression from impaired glucose tolerance to type 2 diabetes: favorable effects of metformin and acarbose]A J Scheen
Pageof 79